ANGO insider trading — Angiodynamics Inc
Over the last 90 days, insiders at Angiodynamics Inc (ANGO) made 0 open-market purchases worth $0 and 1 open-market sale worth $344K, making them net sellers by $344K. The largest sale was by Nighan Warren Jr (SVP Quality and Regulatory), who sold 23,370 shares for $344K on Jul 30, 2026.
Updated Oct 16, 2026.
Recent ANGO insider transactions
Every Form 4 filed by Angiodynamics Inc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Nighan Warren Jr | SVP Quality and Regulatory | S · Sale | Direct | 23,370 | $14.72 | $344K | Form 4 |
| Jul 22, 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | M · Option exercise | Direct | 6,466 | — | — | Form 4 |
| Jul 22, 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | F · Tax withholding | Direct | 2,330 | $13.82 | $32K | Form 4 |
| Jul 22, 2026 | Trowbridge Stephen A | EVP and CFO | M · Option exercise | Direct | 16,296 | — | — | Form 4 |
| Jul 22, 2026 | Trowbridge Stephen A | EVP and CFO | F · Tax withholding | Direct | 8,319 | $13.82 | $115K | Form 4 |
| Jul 22, 2026 | Piccinini Laura | SVP International | M · Option exercise | Direct | 8,047 | — | — | Form 4 |
| Jul 22, 2026 | Piccinini Laura | SVP International | F · Tax withholding | Direct | 4,506 | $13.82 | $62K | Form 4 |
| Jul 22, 2026 | Clemmer James C | President and CEO | M · Option exercise | Direct | 52,358 | — | — | Form 4 |
| Jul 22, 2026 | Clemmer James C | President and CEO | F · Tax withholding | Direct | 26,728 | $13.82 | $369K | Form 4 |
| Jul 22, 2026 | Nighan Warren Jr | SVP Quality and Regulatory | M · Option exercise | Direct | 5,694 | — | — | Form 4 |
| Jul 22, 2026 | Nighan Warren Jr | SVP Quality and Regulatory | F · Tax withholding | Direct | 1,671 | $13.82 | $23K | Form 4 |
| Jul 15, 2026 | Reed Jan Stern | Director | A · Grant/award | Direct | 11,887 | — | — | Form 4 |
| Jul 15, 2026 | Donnelly Howard W | Director | A · Grant/award | Direct | 11,887 | — | — | Form 4 |
| Jul 15, 2026 | Johnson Wesley | Director | A · Grant/award | Direct | 11,887 | — | — | Form 4 |
| Jul 15, 2026 | Piccinini Laura | SVP International | A · Grant/award | Direct | 19,860 | — | — | Form 4 |
| Jul 15, 2026 | Nighan Warren Jr | SVP Quality and Regulatory | A · Grant/award | Direct | 17,966 | — | — | Form 4 |
| Jul 15, 2026 | Burgess Lorinda | Director | A · Grant/award | Direct | 11,887 | — | — | Form 4 |
| Jul 15, 2026 | Weiss Lawrence T | SVP, Chief Legal Officer | A · Grant/award | Direct | 21,288 | — | — | Form 4 |
| Jul 15, 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | A · Grant/award | Direct | 16,081 | — | — | Form 4 |
| Jul 15, 2026 | Tarnoff Michael E | Director | A · Grant/award | Direct | 11,887 | — | — | Form 4 |
| Jul 15, 2026 | Trowbridge Stephen A | EVP and CFO | A · Grant/award | Direct | 53,257 | — | — | Form 4 |
| Jul 15, 2026 | Licitra Karen A | Director | A · Grant/award | Direct | 11,887 | — | — | Form 4 |
| Jul 15, 2026 | Auen Eileen O'Shea | Director | A · Grant/award | Direct | 11,887 | — | — | Form 4 |
| Jul 16, 2026 | Weiss Lawrence T | SVP, Chief Legal Officer | F · Tax withholding | Direct | 2,267 | $14.14 | $32K | Form 4 |
| Jul 20, 2026 | Trowbridge Stephen A | EVP and CFO | F · Tax withholding | Direct | 717 | $13.71 | $10K | Form 4 |
| Jul 17, 2026 | Trowbridge Stephen A | EVP and CFO | F · Tax withholding | Direct | 3,510 | $13.51 | $47K | Form 4 |
| Jul 16, 2026 | Trowbridge Stephen A | EVP and CFO | F · Tax withholding | Direct | 7,840 | $14.14 | $111K | Form 4 |
| Jul 20, 2026 | Piccinini Laura | SVP International | F · Tax withholding | Direct | 616 | $13.71 | $8K | Form 4 |
| Jul 17, 2026 | Piccinini Laura | SVP International | F · Tax withholding | Direct | 3,074 | $13.51 | $42K | Form 4 |
| Jul 16, 2026 | Piccinini Laura | SVP International | F · Tax withholding | Direct | 4,538 | $14.14 | $64K | Form 4 |
| Jul 20, 2026 | Nighan Warren Jr | SVP Quality and Regulatory | F · Tax withholding | Direct | 251 | $13.71 | $3K | Form 4 |
| Jul 17, 2026 | Nighan Warren Jr | SVP Quality and Regulatory | F · Tax withholding | Direct | 1,373 | $13.51 | $19K | Form 4 |
| Jul 16, 2026 | Nighan Warren Jr | SVP Quality and Regulatory | F · Tax withholding | Direct | 2,153 | $14.14 | $30K | Form 4 |
| Jul 20, 2026 | Clemmer James C | President and CEO | F · Tax withholding | Direct | 4,223 | $13.71 | $58K | Form 4 |
| Jul 19, 2026 | Clemmer James C | President and CEO | F · Tax withholding | Direct | 12,251 | $13.51 | $166K | Form 4 |
| Jul 17, 2026 | Clemmer James C | President and CEO | F · Tax withholding | Direct | 10,649 | $13.51 | $144K | Form 4 |
| Jul 16, 2026 | Clemmer James C | President and CEO | F · Tax withholding | Direct | 18,588 | $14.14 | $263K | Form 4 |
| Jul 20, 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | F · Tax withholding | Direct | 359 | $13.71 | $5K | Form 4 |
| Jul 17, 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | F · Tax withholding | Direct | 1,112 | $13.51 | $15K | Form 4 |
| Jul 16, 2026 | Campbell Chad Thomas | SVP/GM, Vascular Access | F · Tax withholding | Direct | 2,367 | $14.14 | $33K | Form 4 |
ANGO insider trading FAQ
Are insiders buying ANGO stock?
Not on the open market. In the last 90 days, Angiodynamics Inc insiders made no open-market purchases, and 1 open-market sale totaling $344K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading ANGO?
Recent sellers: Nighan Warren Jr.
Where does ANGO insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.